ChemoCentryx
CCXI
#3560
Rank
S$4.83 B
Marketcap
S$67.18
Share price
0.00%
Change (1 day)
26.82%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: S$4.83 Billion

On November 25, 2022 ChemoCentryx had a market cap of S$4.83 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022S$5.01 B45.41%
2021S$3.44 B-39.2%
2020S$5.66 B76.52%
2019S$3.21 B325.42%
2018S$0.75 B94.53%
2017S$0.38 B-24.2%
2016S$0.51 B1.13%
2015S$0.50 B29.12%
2014S$0.39 B24.62%
2013S$0.31 B-35.31%
2012S$0.48 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Biogen
BIIB
S$32.21 B 566.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$508.90 B 10,432.16%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$127.22 B 2,532.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
S$140.29 B 2,803.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$648.55 B 13,322.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$225.74 B 4,572.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$183.97 B 3,707.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$44.95 B 830.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
S$325.00 B 6,626.26%๐Ÿ‡บ๐Ÿ‡ธ USA